Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox plus intensive physiotherapy versus intensive physiotherapy alone in children with spastic cerebral palsy
2009-009868-31Phase 4Active
- Sponsor
- ZonMw
- Start
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in cerebral palsy (CP) (2 arms), sponsored by ZonMw. Primary endpoints: Gross Motor Function Measure and Everyday physical activity level. Started May 2009; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on 2009-009868-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009868-31.